Buscar resultados de ensayos clínicos
Leukemia, Mast-Cell - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Condición: Leukemia, Mast-Cell Fecha: 2005-09-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Condición:
Intervenciones: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i |
Recruiting |
Nombre del estudio: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia Condición:
Intervenciones: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib |
Active, not recruiting |
Nombre del estudio: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia Condición: Leukemia Fecha: 2008-10-28 Intervenciones: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati |
Recruiting |
Nombre del estudio: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies Condición:
|
Completed |
Nombre del estudio: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis Condición:
|
Recruiting |
Nombre del estudio: Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia Condición:
|
Completed |
Nombre del estudio: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies Condición:
Intervenciones: |
Completed |
Nombre del estudio: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condición:
Intervenciones: |